Immuneering Corp (IMRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $240.27M
Last updated: Nov 17, 2026 at 11:05 AM ET
Immuneering Corp (IMRX) Competitors
The companies most similar to Immuneering are Kyverna Therapeutics, Inc. Common Stock (KYTX), CorMedix (CRMD) and NeOnc Technologies Holdings, Inc. Common Stock (NTHI). By market cap, Immuneering ranks 9th of the 13 companies on this page; Immix Biopharma (IMMX) is the largest at $657.09M.
Peer Comparison
IMRX's revenue growth of -99.8% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Immuneering (IMRX) | $240.27M | N/A | N/A | 0.0% | N/A | -99.8% | 0.00% |
| Kyverna Therapeutics, Inc. Common Stock (KYTX) | $319.27M | N/A | N/A | 0.0% | -81.5% | 0.0% | 0.00% |
| CorMedix Inc (CRMD) | $370.64M | 6.3x | 0.9x | 15.5% | 13.9% | -47.7% | 0.00% |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | $141.66M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Inovio Pharmaceuticals Inc (INO) | $267.85M | N/A | 462.0x | 0.0% | N/A | -100.0% | 0.00% |
| Indaptus Therapeutics Inc (INDP) | $422.38M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Immunic Inc (IMUX) | $102.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Rocket Pharmaceuticals Inc (RCKT) | $256.82M | N/A | N/A | 0.0% | -2.3% | 0.0% | 0.00% |
| Bright Minds Biosciences Inc (DRUG) | $227.96M | N/A | N/A | 0.0% | -11.2% | 0.0% | 0.00% |
| Century Therapeutics Inc (IPSC) | $299.63M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Keros Therapeutics Inc (KROS) | $202.13M | N/A | 4.9x | -151.4% | N/A | 180.5% | 0.00% |
| Immix Biopharma Inc (IMMX) | $657.09M | N/A | N/A | 0.0% | -14.9% | 0.0% | 0.00% |
| Prelude Therapeutics Inc (PRLD) | $275.32M | N/A | 16.3x | -269.7% | N/A | 41.0% | 0.00% |
| Peer median | $271.59M | 6.3x | 10.6x | 0.0% | -11.2% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Immuneering, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Kyverna Therapeutics, Inc. Common Stock (KYTX) | Kyverna Therapeutics, Inc. is an innovative biotechnology company focused on advancing immunotherapies for autoimmune diseases and other significant health... | KYTX competitors |
| CorMedix Inc (CRMD) | CorMedix Inc., a biopharmaceutical company, focuses on developing and marketing therapeutic products for the prevention and treatment of infectious... | CRMD competitors |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy... | NTHI competitors |
| Inovio Pharmaceuticals Inc (INO) | Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development... | INO competitors |
| Indaptus Therapeutics Inc (INDP) | Indaptus Therapeutics Inc. is a pioneering biotechnology firm focused on advancing immunotherapies that aim to transform cancer treatment paradigms. | INDP competitors |
| Immunic Inc (IMUX) | Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune... | IMUX competitors |
| Rocket Pharmaceuticals Inc (RCKT) | Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. | RCKT competitors |
| Bright Minds Biosciences Inc (DRUG) | Bright Minds Biosciences Inc. (DRUG) is a forward-thinking clinical-stage biotechnology firm specializing in the development of groundbreaking therapies... | DRUG competitors |
| Century Therapeutics Inc (IPSC) | Century Therapeutics Inc. (Ticker: IPSC) is a leading biotechnology company specializing in allogenic cell therapy... | IPSC competitors |
| Keros Therapeutics Inc (KROS) | Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery... | KROS competitors |
| Immix Biopharma Inc (IMMX) | Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology... | IMMX competitors |
| Prelude Therapeutics Inc (PRLD) | Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized... | PRLD competitors |
Frequently Asked Questions About IMRX
Who are Immuneering's main competitors?
The companies most similar to Immuneering include Kyverna Therapeutics, Inc. Common Stock (KYTX), CorMedix (CRMD), NeOnc Technologies Holdings, Inc. Common Stock (NTHI), Inovio Pharmaceuticals (INO) and Indaptus Therapeutics (INDP), listed from the closest match.
Who is Immuneering's biggest competitor?
Immix Biopharma (IMMX) is the largest of the similar companies at $657.09M; Kyverna Therapeutics, Inc. Common Stock (KYTX) is the closest match by business profile, size, sector and industry.
How does IMRX stock compare with its competitors?
IMRX's net margin is 0.0% against a peer median of 0.0%.
Which of Immuneering's competitors pays a higher dividend?
Immuneering pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Immuneering bigger than its competitors?
No. Immuneering is 9th by market cap among the 13 companies on this page; the largest is Immix Biopharma (IMMX) at $657.09M.
IMRX pages: Overview, Earnings, Forecast, Financials, Competitors